eHealth awarded CFO Dolan John Joseph 70,000 shares at $0 per share in a transaction dated September 1, 2026. After the award, his reported eHealth ownership stood at 343,275 shares, giving investors the disclosed post-transaction holding alongside the grant size and recorded Acquisition price.
Key Highlights
- The shares were awarded at $0 per share.
- The transaction took place on September 1, 2026.
- The award was recorded under transaction code A.
EHealth, Inc. (NASDAQ: EHTH) awarded Chief Financial Officer Dolan John Joseph 70,000 shares at $0 per share. The transaction dated September 1, 2026, leaves Joseph with reported ownership of 343,275 eHealth shares.
$0 Share Award Recorded Under Code A
The award carries a stated price of $0 per share. The award involved 70,000 eHealth shares. The transaction date was September 1, 2026. The filing records the award as 70,000 eHealth shares at $0 per share on September 1, 2026. Those terms are the recorded details of the transaction involving eHealth CFO Dolan John Joseph.
Reported Ownership Was 343,275 Shares
Following the transaction, Dolan John Joseph’s reported ownership of eHealth shares stood at 343,275. That figure represents his disclosed holdings after the 70,000-share award.
FAQs
Q: How many eHealth shares did CFO Dolan John Joseph receive?
A: EHealth CFO Dolan John Joseph received 70,000 shares. The award was recorded at $0 per share in a transaction dated September 1, 2026.
Q: What was Dolan John Joseph’s eHealth ownership after the award?
A: Following the transaction, Dolan John Joseph’s reported eHealth ownership was 343,275 shares. The filing identifies him as eHealth’s chief financial officer.
Q: When did the eHealth CFO share award occur?
A: The eHealth share award occurred on September 1, 2026. The transaction was recorded under code A and involved 70,000 shares at $0 per share.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.